Table 3.
Distribution of Genotype and Allele Frequencies of ATG16L1 Polymorphism in Patients with Bladder Cancer (BCa) and Healthy Controls
| Gene/Genotypes | Patients n=69 n/% | Control n=156 n/% | P value | Odds ratio | 95% (CI) | |
|---|---|---|---|---|---|---|
| ATG16L1 | ||||||
| AA | 24 (35) | 50 (32) | - | 1 | - | |
| AG | 28 (40) | 62 (40) | 0.856 | 0.941 | 0.486-1.821 | |
| GG | 17 (25) | 44 (28) | 0.566 | 0.805 | 0.383-1.690 | |
| A | 76 (55) | 162 (52) | ||||
| Alleles | G | 62 (45) | 150 (48) | 0.537 | 1.135 | 0.759-1.697 |